![John R. Garrett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John R. Garrett active positions
Companies | Position | Start | End |
---|---|---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Chief Executive Officer | - | - |
Glycosyn Health Initiatives, Inc. | Director/Board Member | - | - |
Career history of John R. Garrett
Former positions of John R. Garrett
Companies | Position | Start | End |
---|---|---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Director/Board Member | 16/04/2018 | - |
Statistics
International
United States | 3 |
Canada | 2 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
Private companies | 2 |
---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Health Technology |
Glycosyn Health Initiatives, Inc. |
- Stock Market
- Insiders
- John R. Garrett
- Experience